Pathogenic Glycosyltransferase Genes and Potential Therapeutic Drugs in Pressure Overload-Induced Heart Failure
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15409 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Jiahe Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Heart Failure, Glycosyltransferases, Gene Expression Regulation. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Protein glycosylation regulated by glycosyltransferases is an important type of post-translational modification. The role of the glycosyltransferase genes (GTGs) in heart failure (HF) remains unclear and requires further investigation.
Methods
Differential expression analysis was performed on the transverse aortic constriction (TAC)-related dataset GSE36074 to screen out the differentially expressed GTGs. Enrichment and protein–protein interaction analyses explored their functional mechanisms and interconnections. Pearson correlation analysis revealed the relationship between GTGs and pathological cardiac remodelling. The upstream miRNAs of GTGs were predicted using corresponding online databases, and the downstream target genes were identified by weighted correlation network analysis (WGCNA). Computer virtual screening and molecular docking predicted potential therapeutic drugs. The identified GTGs were validated in vivo, in vitro and in the human HF-related dataset GSE57338.
Results
Twenty-one differentially expressed GTGs were identified, and these genes were significantly up-regulated in the TAC model except for C1galt1, Extl2 and Pigh. Pearson correlation analysis revealed that 11 GTGs were significantly associated with pathological cardiac remodelling. Fifty-six miRNAs and 31 drugs were predicted to target these GTGs. WGCNA indicated that these GTGs were associated with lipid metabolism-related genes and pathways. Up-regulation of B3gnt9, C1galt1, Gcnt1, Gxylt2 and Mgat5b was observed in the TAC model. GXYLT2 is up-regulated and has high disease-predictive value in patients with dilated cardiomyopathy and ischaemic cardiomyopathy. Knockdown of GXYLT2 in human AC16 cardiomyocytes significantly attenuated angiotensin II (AngII)-induced hypertrophy.
Conclusions
Dysregulation of GTG expression may affect TAC-induced HF through metabolic pathways, and GXYLT2 may be a new potential therapeutic target for HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, China.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Wu, J., Lu, Y., Gao, X., Hu, X., Lu, Z., & Li, C. (2025). Pathogenic Glycosyltransferase Genes and Potential Therapeutic Drugs in Pressure Overload-Induced Heart Failure. ESC Heart Failure. https://doi.org/10.1002/ehf2.15409
Vancouver
Wu J, Lu Y, Gao X, Hu X, Lu Z, Li C. Pathogenic Glycosyltransferase Genes and Potential Therapeutic Drugs in Pressure Overload-Induced Heart Failure. ESC Heart Failure. 2025. doi:10.1002/ehf2.15409
BibTeX
@article{Wu2025,
author = {Wu, Jiahe and Lu, Yi and Gao, Xinchen and Hu, Xiaorong and Lu, Zhibing and Li, Chenze},
title = {Pathogenic Glycosyltransferase Genes and Potential Therapeutic Drugs in Pressure Overload-Induced Heart Failure},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15409}
}
EUVIMED